Regulation of Erythrocyte Volume Homeostasis
Regulation of Erythrocyte Volume Homeostasis
批准号:
9921353
负责人:
PATRICK G GALLAGHER
金额:
$40.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-15 至 2022-04-30
关键词:
AddressAffectAnemiaAnimal ModelBiologicalBiological AssayCalciumCationsCell CountCell modelCell physiologyCellsClinicalCritical PathwaysDataDehydrationDiseaseElectrophysiology (science)Erythrocyte AgingErythrocyte SurvivalErythrocyte volumeErythrocytesErythroid CellsEsthesiaExhibitsGenesGeneticGenetic studyGenomicsGoalsHemolytic AnemiaHereditary SpherocytosisHomeostasisHydration statusInheritedKnock-inKnock-in MouseKnowledgeLaboratoriesLeadLinkMaintenanceMalariaMediatingMembrane ProteinsMolecularMusMutationNamesPathway interactionsPatientsPermeabilityPhenotypePhysiologicalPiezo 1 ion channelPlayProcessProteinsProteomicsRegulationRoleSeverity of illnessSickle CellSickle Cell AnemiaSodium ChlorideStressStretchingStructureSyndromeTechnologyThalassemiaVariantWaterWorkbasebeta Thalassemiacell typeclinical phenotypecohortgain of functiongain of function mutationgenetic varianthuman diseaseimprovedin vivoin vivo Modelindexinginnovationloss of functionmouse modelmultidisciplinarymutantnovelprotein expressionrare variantside effectsolutetrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
PIEZO1 has recently been identified as the long sought after protein involved in mammalian mechano-
sensation and stretch-activated cation channel activation. We have discovered mutations in PIEZO1 lead to
hereditary xerocytosis, a hemolytic anemia characterized by primary erythrocyte dehydration, indicating
PIEZO1 plays a critical role in cellular volume homeostasis. PIEZO1 is a candidate for the unidentified stretch-
induced calcium-activated cation pathways in the red blood cell that play critical roles in erythrocyte aging,
malaria invasion, and circulatory sheer stress. Preliminary data also indicate that PIEZO1 is an excellent
candidate for Psickle, an unidentified cation permeability pathway induced by deoxygenation in sickle
erythrocytes, at the initiation of the dehydration cascade. Therefore, Psickle is of fundamental importance to
sickle cell pathobiology. Despite its importance, we have no knowledge of the mechanisms controlling PIEZO1
expression, structure, or function in erythroid cells. The overall goal of this proposal is to begin to elucidate the
molecular mechanisms involved in PIEZO1 regulation and function in erythroid cells. Our preliminary studies
indicate that variants of the PIEZO1 gene occur in hereditary xerocytosis and sickle cell disease patients and
that these variants are associated with alterations in erythrocyte hydration. The goal of aim one is identification
of genetic variants influencing erythrocyte hydration in patients with sickle cell disease and increased numbers
of dense cells and characterization of the effect of these mutations on PIEZO1 expression, structure and
function. The goal of aim two is to create a murine model of hereditary xerocytosis and analyze the influence of
HX-associated Piezo1 gain of function mutations in vivo on wild type and sickle cell backgrounds. The goal of
aim 3 is the characterization of the influence of Piezo1 loss of function on erythrocyte function in wild type and
SCD erythrocytes to better understand molecular mechanisms regulating erythrocyte volume homeostasis, to
address the hypothesis that PIEZO1 mediates the cation currents of Psickle, the unidentified, incipient transport
pathway critical for dehydration of sickle erythrocytes, and to assess the influence of Piezo1 deficiency on
parameters of sickle cell disease. To address the influence of mutations on PIEZO1 structure and function,
functional cell-based assays of PIEZO1 membrane protein expression, trafficking, and electrophysiology in a
novel, in vivo stably-transfected, single-copy, inducible cell model of PIEZO1 expression will be performed.
Physiologic studies of mature erythrocytes from genetically modified mice and affected patients will be
performed under a variety of cellular conditions. PIEZO1 is expressed in many cell types, indicating PIEZO1
likely mediates important functions in a wide variety of cells. Thus studies in erythroid cells may yield
mechanistic or biological principles generalizable to many critical cellular processes or human diseases.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
A Ser725Arg mutation in Band 3 abolishes transport function and leads to anemia and renal tubular acidosis.
带 3 中的 Ser725Arg 突变会消除转运功能并导致贫血和肾小管酸中毒。
DOI:
10.1182/blood-2018-01-827725
发表时间:
2018
期刊:
Blood
影响因子:
20.3
作者:
[Yang,Elizabeth, Seo-Mayer,Patricia, Lezon-Geyda,Kimberly, Badior,KatherineE, Li,Jing, Casey,JosephR, Reithmeier,ReinhartAF, Gallagher,PatrickG]
通讯作者:
Gallagher,PatrickG
DOI:
10.1111/ijlh.12357
发表时间:
2015-05
期刊:
International journal of laboratory hematology
影响因子:
3
作者:
[Glogowska E, Gallagher PG]
通讯作者:
Gallagher PG
DOI:
10.1002/pbc.26444
发表时间:
2017-08
期刊:
Pediatric blood & cancer
影响因子:
3.2
作者:
[Yang E, Voelkel EB, Lezon-Geyda K, Schulz VP, Gallagher PG]
通讯作者:
Gallagher PG
Novel Mechanisms of Congenital Dyserythropoietic Anemia
-
批准号:10454333
-
项目类别:
-
资助金额:$41.84万
-
财政年份:2020
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Novel Mechanisms of Congenital Dyserythropoietic Anemia
-
批准号:9887377
-
项目类别:
-
资助金额:$41.84万
-
财政年份:2020
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Novel Mechanisms of Congenital Dyserythropoietic Anemia
-
批准号:10192709
-
项目类别:
-
资助金额:$41.84万
-
财政年份:2020
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Nonenzymatic Gene Editing in Treatment of Heredity Spherocytosis
-
批准号:10305603
-
项目类别:
-
资助金额:$62.02万
-
财政年份:2019
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Coordinated regulation of vascular smooth muscle phenotype by p300, CBP, and TET2
-
批准号:10308706
-
项目类别:
-
资助金额:$54.85万
-
财政年份:2018
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Responsiveness and non-responsiveness to transfused RBCs in mice and humans.
-
批准号:9918440
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2017
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Center of Excellence in Hematology
-
批准号:10454355
-
项目类别:
-
资助金额:$81.39万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Hematology Specialized Core Center
-
批准号:9987207
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Center of Excellence in Hematology
-
批准号:10249339
-
项目类别:
-
资助金额:$81.39万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Hematology Specialized Core Center
-
批准号:8972977
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Hematology Specialized Core Center
-
批准号:9325318
-
项目类别:
-
资助金额:$80.71万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Hematology Specialized Core Center
-
批准号:9763197
-
项目类别:
-
资助金额:$2.36万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Center of Excellence in Hematology
-
批准号:10060455
-
项目类别:
-
资助金额:$100.19万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Hematology Specialized Core Center
-
批准号:9544538
-
项目类别:
-
资助金额:$1.06万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Yale Cooperative Hematology Specialized Core Center
-
批准号:9763598
-
项目类别:
-
资助金额:$78.2万
-
财政年份:2015
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Regulation of Erythrocyte Volume Homeostasis
-
批准号:8927631
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2014
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Regulation of Erythrocyte Volume Homeostasis
-
批准号:9382408
-
项目类别:
-
资助金额:$42.96万
-
财政年份:2014
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Barrier Insulators in Erythropoiesis
-
批准号:8585873
-
项目类别:
-
资助金额:$40.79万
-
财政年份:2011
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Barrier Insulators in Erythropoiesis
-
批准号:8025615
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2011
-
负责人:PATRICK G GALLAGHER
-
依托单位:
Barrier Insulators in Erythropoiesis
-
批准号:8389605
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2011
-
负责人:PATRICK G GALLAGHER
-
依托单位:
海外基金